Strengthening Translational Research in Diverse Enrollment (STRIDE) offers several promising innovations intended to improve participation of African Americans and Latinos in clinical trials and other translational research, a high priority area. Specifically, STRIDE will enhance consent and recruitment protocols to promote enhance racial and ethnic minority participation by addressing barriers at multiple levels (participant, research team, system) with an integrated leading-edge e-Consent platform that will be culturally, linguistically, and literacy-tailored and will promote and assess participant comprehension of the informed consent process. 

This capacity integrates and expands upon promising approaches developed at partnering CTSAs, leveraging collective strengths in community engagement and health disparities (UMass), e-content and REDCap (Vanderbilt) and clinical trials methodology (CCTS). Grounded in the principles of equitable community engagement in collaboration with Community Campus Partnerships for Health (CCPH), STRIDE will use a culturally competent, community-engaged approach to increase participant receptivity and ultimately effectiveness of the intervention on increasing research participation among diverse populations. The tool will be applicable to a wide range of clinical trials and other translational research.


STRIDE Logo Final